SB 895 amends West Virginia's workers' compensation code to allow claimants to file an initial claim or reopen an occupational pneumoconiosis claim at any time if evidence shows pulmonary massive fibrosis (PMF). The bill adds §23-4-8e to override specified time limits in existing law and reaffirms an impairment rating tied to a diagnosis of PMF.
The change targets late-manifesting, severe lung disease in miners by removing procedural barriers that currently bar late claims or reopenings. That shifts long-term financial exposure back onto insurers, self-insured employers and the workers' compensation fund while creating clearer, but potentially contested, diagnostic and adjudicative pathways for PMF cases.
At a Glance
What It Does
SB 895 creates a carve-out to existing filing and reopening deadlines so that any claim showing pulmonary massive fibrosis may be filed or reopened without time limitation. It inserts a new §23-4-8e and amends related sections addressing occupational pneumoconiosis and awards.
Who It Affects
Coal miners and other workers with occupational dust exposure who develop PMF, insurers and self-insured employers covering miners, the West Virginia Workers' Compensation Commission and medical examiners and radiologists who will supply diagnostic evidence.
Why It Matters
The bill eliminates a procedural cutoff that has prevented late-stage black lung claims, likely increasing retroactive liabilities and litigation. For compliance officers and claims managers this means reevaluating underwriting, reserves and procedures for long-tail pneumoconiosis claims.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds a targeted exception to West Virginia's time-limit framework for occupational disease claims. New §23-4-8e says that if a claimant can show pulmonary massive fibrosis—defined elsewhere in the code by imaging criteria—then the usual deadlines for filing an initial claim or reopening a closed claim do not apply.
In practice, that means someone diagnosed decades after last exposure can bring or reopen a workers' compensation claim without running afoul of the five-year closure or reopening windows that otherwise limit such actions.
Procedurally, the carve-out is framed as an override of three specific code provisions that establish deadlines: the impairment determination subsection, a related subsection addressing processing of pneumoconiosis claims, and the reopening/continuing jurisdiction rules. The bill does not create a new evidentiary standard in §23-4-8e; it relies on the existing definition and diagnostic rules in §23-4-1(d), which refer to one or more large opacities (>1 cm) diagnosed by x-ray or CT according to currently adopted pneumoconiosis standards.
That means the dispute over what constitutes sufficient “evidence” of PMF will land on medical reports and imaging interpretations, not on an automatic statutory trigger.On awards, the legislation ties into existing impairment rules: a diagnosis of progressive massive fibrosis is treated as a fifteen percent whole-body medical impairment under the commission's current framework. The bill leaves intact other mechanics—such as the commission's authority to allocate responsibility among multiple employers and the commission's role in monitoring and reopening permanent total disability awards—but it eliminates the temporal bar that previously limited when claimants could ask for modification or reopening based on progressive disease.Operationally, claim administrators will need new intake and review pathways for old exposures, and medical panels or examiners will play a heightened gatekeeping role.
The commission will likely have to issue guidance or rules interpreting what evidence satisfies the PMF threshold, how remote employers are identified and apportioned liability, and how examinations performed long after exposure should be credited. The bill does not expressly alter interactions with federal black lung benefits programs or other statutory offsets, so coordination between federal and state benefits will remain an implementation issue the commission and payors must manage.
The Five Things You Need to Know
New §23-4-8e eliminates any filing or reopening time limits for occupational pneumoconiosis claims when evidence demonstrates pulmonary massive fibrosis is present.
PMF is defined in existing §23-4-1(d) as one or more large opacities greater than 1 centimeter on x-ray or CT, diagnosed per currently adopted pneumoconiosis standards.
A diagnosis of progressive massive fibrosis is treated as a 15% whole-body medical impairment under §23-4-6(i), which the bill preserves as the baseline impairment rating.
The carve-out expressly overrides the deadlines in §23-4-6(i), §23-4-6a, and §23-4-16(a)(2), meaning the five-year closure and reopening windows no longer apply to PMF claims.
The commission's existing allocation rules remain available: when multiple employers are implicated, the commission may divide charges based on time and degree of exposure among employers.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
No time limit to file or reopen a PMF claim
This new section is the bill's operative change: it states that a claimant may file an initial claim or reopen an occupational pneumoconiosis claim without any time limit if evidence shows pulmonary massive fibrosis. Practically, this removes the procedural bars that previously prevented late claims and reopens closed files where PMF is subsequently diagnosed. The text leaves the evidentiary question—what ‘‘demonstrates the presence’’ of PMF—to existing diagnostic standards rather than creating a new statutory proof rule.
Clarifies PMF in definitions and diagnostic references
The bill amends the foundational definitions in Article 4 to emphasize the Legislature's recognition of PMF as more severe and progressive than simple pneumoconiosis. §23-4-1 already defines pulmonary massive fibrosis by imaging criteria; the amendments tie that definition more firmly into the compensable-injury framework so that when PMF is diagnosed the new time-limit exception applies. This keeps diagnosis anchored to radiographic/CT criteria rather than to subjective symptom-based standards.
Affirms impairment treatment for PMF within award schedule
The bill modifies the section of the disability schedule that governs how permanent partial disability is measured and awarded. It preserves the existing treatment that a PMF diagnosis constitutes a 15% whole-body medical impairment and ensures that impairment rating operates alongside the new filing carve-out. In other words, claimants who successfully invoke the time-limit exception will be evaluated under the same impairment mechanics already codified in the statute.
Overrides reopening and continuous-jurisdiction limits for PMF
Changes to §23-4-16 remove the five-year limitations that govern requests to reopen claims and to modify awards when PMF is present. The section preserves the commission's continuing jurisdiction for other purposes but makes clear that the temporal restraint on reopening is inapplicable to PMF claims. That creates potential for reopening long-closed claims and obliges the commission to process those requests even when the last exposure occurred many years earlier.
This bill is one of many.
Codify tracks hundreds of bills on Employment across all five countries.
Explore Employment in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Coal miners and other dust-exposed workers diagnosed with PMF — They can file new claims or reopen closed claims regardless of how long ago exposure ended, enabling recovery of compensation and medical benefits tied to a late-manifesting, severe disease.
- Surviving dependents of miners with late-diagnosed PMF — Eliminating time bars may allow dependent claims for death benefits that were previously time-barred if PMF is shown to have been present.
- Plaintiff-side attorneys and claimant advocates — More potential meritorious claims and reopenings increase opportunities for representation and recovery, shifting the practical balance in adjudication toward claim reexamination.
Who Bears the Cost
- Insurers and self-insured employers (including coal operators) — They face expanded long-tail liability for PMF claims, potentially requiring increased reserves, premium adjustments, and disputed allocations among current and historical employers.
- West Virginia Workers' Compensation Commission — The commission will absorb increased administrative workload from reopening and processing older claims and will need to develop guidance on evidentiary thresholds and allocation procedures.
- Payers of public funds (state insurance funds and possibly taxpayers) — If private carriers or insolvent former employers cannot be located or allocated, costs may fall to state-administered funds, increasing budgetary pressure.
Key Issues
The Core Tension
The bill balances two legitimate objectives that pull in opposite directions: protecting miners who develop a severe, progressive disease long after exposure versus containing indefinite financial and evidentiary exposure for employers, insurers and state funds. Removing time bars helps claimants with late-manifesting PMF but creates long-tail liability, evidentiary uncertainty and administrative strain—there is no simple policy that simultaneously guarantees timely compensation and predictable, bounded employer exposure.
The statute's operative phrase—allowing claims where evidence "demonstrates the presence of pulmonary massive fibrosis"—is compact but legally capacious. The bill relies on preexisting diagnostic language that points to radiographic criteria, yet it leaves unresolved how the commission will treat competing readings, remote imaging obtained years after exposure, or later-developed connective tissue disease that complicates interpretation.
That ambiguity will likely be litigated early and often, and will shape whether the carve-out admits a broad set of late claims or a narrower class supported by contemporaneous objective imaging.
Another implementation knot is allocation and solvency. The code preserves the commission's ability to apportion liability among employers based on time and degree of exposure, but practically speaking many responsible employers may no longer exist or be insured.
That raises questions about what portion of reopened awards will be shifted to state funds, how offsets under federal black lung benefits are coordinated, and whether employers and carriers will challenge reopening on statutory or constitutional grounds. Finally, the bill does not provide transitional procedures or funding for the expected increase in claims, so administrative capacity, timelines for medical review, and the cost of retrospective examinations are practical issues left to the commission and payors to resolve.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.